邱騰華向泰商界介紹香港營商優勢

商務及經濟發展局局長邱騰華今日在泰國曼谷與泰國副總理兼商務部長Jurin Laksanawisit會面，又向當地商界介紹香港最新的貿易和經濟發展，並討論如何加強區域合作。邱騰華周末出席在曼谷舉行的亞太區經濟合作組織貿易部長會議。會議前，他與Jurin Laksanawisit會面，就加強港泰雙邊貿易關係交流。繼2019年簽訂加強兩地經濟關係諒解備忘錄後，雙方希望在電影、創意產業、旅遊、高端科技等領域加強雙邊合作。邱騰華與當地商界領袖會面期間，介紹香港的營商優勢和投資機遇，以及香港在粵港澳大灣區發展和「一帶一路」建設中擔當的角色。此外，他到訪亞洲區內最大物流集團成員之一、在香港創立的物流公司，了解當地的企業發展。邱騰華並禮節拜會中國駐泰國大使韓志強。
http://dlvr.it/SQk7tK

此網誌的熱門文章

香港 Backlinks 網站，中文本地 SEO 必備

市面上的 Backlinks 多數來自外國英文網站，對於香港網站未能精準地改善中文版 Google 排名，有見及此，有 IT 公司推出為香港公司而設的繁體中文 Backlinks 服務，在 100 多個高誠信度的新聞網站刊登文案，增加香港 Backlinks ，大大提升中文版 Google 排名。新聞網站包括： https://www.buyinghongkong.com https://www.eatinghongkong.com https://www.playinghongkong.com https://www.relaxhongkong.com https://www.hk-bfn.com https://www.hk-cln.com https://www.hk-swn.com https://www.biznews.org.hk https://www.building.org.hk https://www.citylife.org.hk https://www.educate.org.hk https://www.healthy.org.hk https://www.hongkong.org.hk https://www.lohas.org.hk https://www.funding.org.hk https://www.tvp.org.hk https://www.bud.org.hk https://www.smefund.org.hk https://news.business138.com https://news.corporate138.com https://news.company138.com https://news.product138.com https://news.service138.com https://news.solution138.com https://news.website138.com https://news.supplier138.com https://news.vendor138.com https://news.directory138.com https://news.business228.com https:

Hong Kong Science Park: Healthy ecosystem cultivates powerful global collaboration

(English) A healthy ecosystem cultivates powerful global collaboration BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level. bit.ly/3yW8S0f You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines. Q: What's mRNA's superpower? A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment. Q: What's InnoRNA's superpower? A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment. Q: What's HKSTP's superpower? A: Hong Kong is the world's number two biotech funding hub. We will leave you to find out more! Follow our page for more biotech news in Hong Kong and beyond. Reference : ht

HKSTP Park Company Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform

Congratulations! Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform and the lentiviral vector production system developed by their team based at our Park. Millions of people globally are suffering from different type of cancers. Our park company, Eurekabio, specialises in manufacturing supplies and platform for Cell and Gene Therapies (CGT). Thank you Eurekabio for playing a pivotal role in accelerating the development of CGT through automation - Standardising cell processing procedures - Increasing efficiency - Reducing human error and contamination Learn more: https://lnkd.in/gEGmc7Vz Follow our page for more fundraising news happening in our thriving ecosystem. More Information : https://www.hkstp.org/what-we-offer/institute-for-translational-research-overview/

香港新聞網 Service368

搜尋此網誌